浅谈慢性阻塞性肺疾病的辨证治疗研究进展
A Brief Discussion on the Research Progress of Syndrome Differentiation Treatment in Chronic Obstructive Pulmonary Disease

慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease，COPD，简称慢阻肺病)是一种因呼吸道/肺部组织发生异常导致持续性气流阻塞的慢性肺部异质性状态，其特征为由气道和/或肺泡异常所致的慢性呼吸道症状(呼吸困难、咳嗽、咳痰)，引起持续进行性加重的气流阻塞。是最常见的慢性呼吸道疾病，也是也是《健康中国2030行动计划》重点防治疾病之一。由于具有高发病率、高致残率、高死亡率的特点，被认为是世界各地发病率和死亡率的主要原因之一，给全球人类带来沉重的经济负担和生命健康威胁。近年来，中医药防治COPD具有较好的临床疗效，并获得了一些显著成果。文章旨在慢性阻塞性肺疾病中医辩证前提下，对中医药治疗对于治疗慢性阻塞性肺疾病的治疗或改善情况进行研究，并探索中医药在治疗慢性阻塞性肺疾病的临床应用价值。
Chronic Obstructive Pulmonary Disease (COPD, referred to as chronic bronchitis) is a chronic heterogeneous lung condition characterized by persistent airflow obstruction caused by the destruction of airway/pulmonary tissue. It is marked by chronic respiratory symptoms (shortness of breath, cough, sputum production) due to abnormalities in the airways and/or alveoli, leading to progressively worsening airflow obstruction. It is the most common chronic respiratory disease and one of the key diseases targeted for prevention and treatment in the “Healthy China 2030 Action Plan”. Due to its high incidence, high disability rate, and high mortality rate, it is considered one of the main causes of morbidity and mortality worldwide, imposing a heavy economic burden and health threat to global populations. In recent years, TCM has demonstrated good clinical efficacy in the prevention and treatment of COPD, achieving some significant results. This article aims to study the therapeutic or improvement effects of traditional Chinese medicine in treating chronic obstructive pulmonary disease under the dialectical premise of TCM, exploring the clinical application value of TCM in the treatment of COPD.